Wolverine plus

Wolverine+ Protocol (Research-Grade Specification)

The Wolverine+ formulation is designed to align more closely with research-backed ratios and concentrations observed in current peptide literature. It combines TB-500 and BPC-157 in a 2:1 ratio, consistent with the majority of research-grade administration protocols for regenerative and repair-focused applications.

Composition:

• TB-500: 10 mg
• BPC-157: 5 mg

This research blend supports studies focused on synergistic tissue regeneration, inflammation modulation, and enhanced recovery outcomes. When used in a cyclical pattern (e.g., multiple administrations over a span of days per week for a 2-week observational period), the compound combination may optimize localized cellular repair mechanisms and systemic resilience.

This protocol is intended for research purposes only. Not for human consumption.

Products are provided in lyophilized powder form and require reconstitution prior to use in research or laboratory testing.